In Response to: 'Impact of Glycosylation on Effector Functions of Therapeutic IgG' (Pharmaceuticals 2010, 3, 146-157)
To complete the review article by Abes and colleagues (Pharmaceuticals 2010, 3, 146-157) which provides a good overview on recently developed approaches for generation of glyco-modified antibodies and the impact of glyco-modification of antibodies on their effector functions, important information s...
Saved in:
Main Authors: | Andreas Nechansky (Author), Iris Koller (Author), Ralf Kircheis (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2010-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of Glycosylation on Effector Functions of Therapeutic IgG
by: Jean-Luc Teillaud, et al.
Published: (2010) -
Multivariate quantitative analysis of glycan impact on IgG1 effector functions
by: Tamara Cvijić, et al.
Published: (2024) -
Glycosylation of random IgG distinguishes seropositive and seronegative rheumatoid arthritis
by: I. Magorivska, et al.
Published: (2018) -
Juvenile idiopathic arthritis is associated with potentially pathogenic glycosylation of IgG
by: Ercan Altan, et al.
Published: (2012) -
The evaluation of IgG4 and IgG expression in cutaneous Rosai-Dorfman disease
by: Puyu Zou, et al.
Published: (2023)